Compounds > technetium tc 99m hydroxymethylene diphosphonate
Page last updated: 2024-09-03

technetium tc 99m hydroxymethylene diphosphonate and Cancer of Oropharnyx

technetium tc 99m hydroxymethylene diphosphonate has been researched along with Cancer of Oropharnyx in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Camacho, V; Carrió, I; Catafau, A; Estorch, M; Flotats, A; Mena, E; Tembl, A1

Other Studies

1 other study(ies) available for technetium tc 99m hydroxymethylene diphosphonate and Cancer of Oropharnyx

ArticleYear
[99mTc-HDP uptake by soft tissue secondary to hypercalcemia].
    Revista espanola de medicina nuclear, 2002, Volume: 21, Issue:4

    Topics: Carcinoma, Squamous Cell; Humans; Hypercalcemia; Laryngeal Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Oropharyngeal Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tissue Distribution; Viscera

2002